SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DFRN14A - Revised definitive proxy statement filed by non-management:
SEC Accession No. 0000902664-20-000875
Filing Date
2020-02-11
Accepted
2020-02-11 17:20:06
Documents
2
Effectiveness Date
2020-02-11

Document Format Files

Seq Description Document Type Size
1 ENZO BIOCHEM, INC. p20-0546dfrn14a.htm DFRN14A 149874
2 GRAPHIC image_001.jpg GRAPHIC 19972
  Complete submission text file 0000902664-20-000875.txt   179233
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Subject) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: DFRN14A | Act: 34 | File No.: 001-09974 | Film No.: 20598134
SIC: 8071 Services-Medical Laboratories

Mailing Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203
Business Address HARBERT DISCOVERY FUND GP, LLC 2100 THIRD AVENUE NORTH, SUITE 600 BIRMINGHAM AL 35203 205-987-5500
Harbert Discovery Fund, LP (Filed by) CIK: 0001626127 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DFRN14A